Introduction: The AYUSH Sector in India

AYUSH encompasses Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy, representing India's traditional medicine systems. Governed by the Ministry of AYUSH since its establishment in 2014, the sector aligns with Article 47 of the Constitution, which directs the state to improve public health. The National Health Policy 2017 explicitly promotes AYUSH integration into mainstream healthcare, reflecting a strategic policy shift. India's AYUSH market is projected to reach USD 18 billion by 2025, with a compound annual growth rate (CAGR) of 16.5% (FICCI 2023), underscoring both health and economic potential.

Legal and Constitutional Framework Governing AYUSH

The AYUSH sector operates under a robust legal framework. The Indian Medicine Central Council Act, 1970 regulates education and practice standards, while the National Commission for Indian System of Medicine Act, 2020 (Sections 3-10) modernizes regulatory oversight for education and professional standards. The Drugs and Cosmetics Act, 1940, amended in 2020, incorporates AYUSH drug regulations, ensuring quality and safety. These laws collectively institutionalize AYUSH within India’s healthcare landscape, fulfilling the Directive Principles under Article 47 of the Constitution.

• National AYUSH Mission covers 27 states and union territories with an annual budget of INR 1,300 crore (2023), focusing on infrastructure and research.
• Ministry of AYUSH budget increased to INR 2,500 crore in 2023-24, reflecting government prioritization (Union Budget 2024).
• Integration into public health is limited; only 15% of public health facilities offer AYUSH services (National Health Profile 2023).

Economic Dimensions and Market Potential

The AYUSH sector is a significant contributor to India’s health economy. Employing over 7 million practitioners (Ministry of AYUSH Annual Report 2023), it supports livelihoods and rural economies. Export growth from USD 180 million in 2019 to USD 250 million in 2023 (APEDA Report) indicates rising global demand. Wellness tourism linked to AYUSH generates approximately USD 3 billion annually, with a projected CAGR of 20% until 2027 (NITI Aayog 2023). Research funding under the National AYUSH Mission increased by 30% in 2023, fostering scientific validation.

• FICCI 2023 projects AYUSH market size at USD 18 billion by 2025 with 16.5% CAGR.
• Government budgetary support increased by 25% between 2022 and 2024.
• Wellness tourism linked to AYUSH is a growing foreign exchange earner and employment generator.

Key Institutions Driving AYUSH Development

Institutional architecture is critical for AYUSH’s growth and integration. The Ministry of AYUSH formulates policy and promotes traditional medicine. The Central Council of Indian Medicine (CCIM) regulates education and practice standards. Research is led by the Central Council for Research in Ayurvedic Sciences (CCRAS) and the National Institute of Ayurveda (NIA). The Food Safety and Standards Authority of India (FSSAI) regulates AYUSH-related food products, ensuring consumer safety. The Export Promotion Council for Handicrafts (EPCH) facilitates AYUSH product exports, linking traditional knowledge with global markets.

• CCIM and National Commission for Indian System of Medicine together govern education standards.
• CCRAS has increased research publications by 40% between 2018 and 2023 (Scopus Database).
• FSSAI’s AYUSH food category enhances regulatory clarity for nutraceuticals.

Comparative Analysis: India’s AYUSH vs. China’s Traditional Chinese Medicine (TCM)

Critical Gaps Limiting AYUSH’s Potential

Despite policy backing, AYUSH faces integration and validation challenges. Fragmented regulatory frameworks and limited scientific evidence hinder mainstream acceptance. Only 15% of public health facilities integrate AYUSH, constraining accessibility. Research remains underfunded compared to TCM, and the sector suffers from inconsistent quality control. These gaps limit AYUSH’s scalability and global competitiveness.

• Need for unified regulatory standards across AYUSH streams.
• Enhancement of clinical research and evidence-based validation.
• Greater integration with allopathic healthcare systems for comprehensive care.

Significance and Way Forward

Strategic leveraging of AYUSH can improve health outcomes, generate economic growth, and enhance India’s soft power globally. Policy focus should prioritize:

• Strengthening regulatory coherence under the National Commission for Indian System of Medicine.
• Expanding AYUSH integration in public health from 15% to at least 50% by 2030.
• Increasing research funding to match global standards and facilitate evidence-based practice.
• Promoting AYUSH-linked wellness tourism with international marketing and quality assurance.
• Enhancing export infrastructure and removing trade barriers for AYUSH products.

These steps will align AYUSH with constitutional mandates and economic objectives, unlocking its full potential.